• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者年龄与浅表性移行细胞癌特征之间的关系。

Relationship between patient age and superficial transitional cell carcinoma characteristics.

作者信息

Shi Benkang, Zhang Keqin, Zhang Jing, Chen Jun, Zhang Nianzhao, Xu Zhishun

机构信息

Department of Urology, Qilu Hospital of Shandong University, Jinan, China.

出版信息

Urology. 2008 Jun;71(6):1186-90. doi: 10.1016/j.urology.2008.01.062. Epub 2008 Apr 18.

DOI:10.1016/j.urology.2008.01.062
PMID:18372010
Abstract

OBJECTIVES

To evaluate the relationship between patient age and the characteristics of superficial transitional cell carcinoma.

METHODS

The clinical and pathologic records of 576 patients were retrospectively reviewed. The patients were classified into three groups: those 40 years or younger, those 41 to 59 years old, and those 60 years or older. The transitional cell carcinoma characteristics of three groups were analyzed to define the relationship, if any, with age.

RESULTS

The male/female ratio was 4.1:1, 3.6:1, and 2.3:1 in the three age groups, with significant differences between the 60 years or older group and the 40 years or younger group and 41 to 59 year group (P <0.05). The percentage of patients with poorly differentiated tumor increased with increasing age, and a significant difference was found between the 60 years or older group and the 40 years or younger and 41 to 59 year groups (P <0.05). The overall recurrence rate was 34.2% at 12 months and 40.8% at 24 months. The nonrecurrence rate was significantly greater in those 40 years or younger compared with those 60 years or older in all three risk groups (P <0.05).

CONCLUSIONS

The results of our study have shown that the percentage of female patients with bladder cancer increases with increasing age and that elderly patients are more likely to present with poorly differentiated bladder cancer. Also, the recurrence-free survival rate decreased with increasing age.

摘要

目的

评估患者年龄与浅表性移行细胞癌特征之间的关系。

方法

回顾性分析576例患者的临床和病理记录。将患者分为三组:40岁及以下、41至59岁、60岁及以上。分析三组的移行细胞癌特征,以确定与年龄的关系(若有)。

结果

三个年龄组的男女比例分别为4.1:1、3.6:1和2.3:1,60岁及以上组与40岁及以下组以及41至59岁组之间存在显著差异(P<0.05)。低分化肿瘤患者的百分比随年龄增长而增加,60岁及以上组与40岁及以下组以及41至59岁组之间存在显著差异(P<0.05)。12个月时的总体复发率为34.2%,24个月时为40.8%。在所有三个风险组中,40岁及以下患者的无复发率显著高于60岁及以上患者(P<0.05)。

结论

我们的研究结果表明,膀胱癌女性患者的百分比随年龄增长而增加,老年患者更易出现低分化膀胱癌。此外,无复发生存率随年龄增长而降低。

相似文献

1
Relationship between patient age and superficial transitional cell carcinoma characteristics.患者年龄与浅表性移行细胞癌特征之间的关系。
Urology. 2008 Jun;71(6):1186-90. doi: 10.1016/j.urology.2008.01.062. Epub 2008 Apr 18.
2
Clinical characteristics of bladder urothelial tumors in female patients.女性患者膀胱尿路上皮肿瘤的临床特征。
Menopause. 2010 Mar;17(2):421-5. doi: 10.1097/gme.0b013e3181b63dc4.
3
[Clinical observations on bladder cancer--difference in clinical features with age].膀胱癌的临床观察——临床特征随年龄的差异
Hinyokika Kiyo. 1993 Dec;39(12):1131-8.
4
[Bladder cancer in elderly patients].
Hinyokika Kiyo. 1984 Dec;30(12):1793-9.
5
Differences in tumor characteristics and prognosis in newly diagnosed Ta, T1 urothelial carcinoma of bladder according to patient age.根据患者年龄,新诊断的膀胱Ta、T1期尿路上皮癌的肿瘤特征和预后差异。
Urology. 2009 Apr;73(4):828-32, 832.e1. doi: 10.1016/j.urology.2008.10.038. Epub 2009 Feb 4.
6
Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.膀胱Ta T1期低级别和中级别的移行细胞癌:复发率及第一年膀胱镜检查的时间安排
Urol Int. 2008;80(2):124-8. doi: 10.1159/000112600. Epub 2008 Mar 19.
7
Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.老年人群膀胱保留治疗:肌层浸润性膀胱癌的结果及预后因素
Am J Clin Oncol. 2009 Aug;32(4):333-7. doi: 10.1097/COC.0b013e31818b9486.
8
[Transitional cell bladder carcinoma in patients younger than 40 years of age].40岁以下患者的移行细胞膀胱癌
Arch Esp Urol. 1998 Dec;51(10):991-4.
9
Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma.弥漫性尿路上皮癌患者转移模式与原发性肿瘤特征及治疗的关系
J Urol. 1996 Jan;155(1):111-4.
10
Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades.20年间观察到的非侵袭性膀胱肿瘤复发模式的变化。
J Urol. 2007 Mar;177(3):867-75; discussion 875. doi: 10.1016/j.juro.2006.10.048.

引用本文的文献

1
Clinical behavior and survival outcome of urothelial bladder cancer in young adults.年轻成人尿路上皮膀胱癌的临床行为和生存结果
Urol Ann. 2022 Apr-Jun;14(2):162-166. doi: 10.4103/ua.ua_15_21. Epub 2022 Apr 18.
2
Quantitative Analysis of Tumor-Associated Mast Cells in Recurrent and Non-recurrent Urothelial Bladder Cancer in Stage pTa and pT1.pTa和pT1期复发性和非复发性尿路上皮膀胱癌中肿瘤相关肥大细胞的定量分析
Cureus. 2021 Apr 5;13(4):e14311. doi: 10.7759/cureus.14311.
3
Involvement of Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and the PI3K/AKT/mTOR Pathway in Nobiletin-Induced Apoptosis of Human Bladder Cancer Cells.
桔皮素诱导人膀胱癌细胞凋亡过程中线粒体功能障碍、内质网应激及 PI3K/AKT/mTOR 通路的作用
Molecules. 2019 Aug 8;24(16):2881. doi: 10.3390/molecules24162881.
4
Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.软珊瑚 Cladiella kashmani 中提取的 Flaccidoxide-13-Acetate 通过降低 FAK/PI3K/AKT/mTOR 信号通路的激活来减少人膀胱癌细胞的迁移和侵袭。
Molecules. 2017 Dec 27;23(1):58. doi: 10.3390/molecules23010058.
5
Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.辛纳利奥内酯通过抑制 PI3K/AKT/mTOR 信号通路抑制基质金属蛋白酶-2/-9 和尿激酶从而抑制人膀胱癌细胞的迁移和侵袭。
Mar Drugs. 2017 Aug 2;15(8):238. doi: 10.3390/md15080238.
6
Urothelial Carcinoma in a 22-Year-Old Female with Angelman Syndrome.一名患有天使综合征的22岁女性的尿路上皮癌。
Case Rep Urol. 2017;2017:9298565. doi: 10.1155/2017/9298565. Epub 2017 Apr 11.
7
Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patients.80岁以上患者首次组织学诊断的尿路上皮癌具有独特的组织学特征:一项对185例患者的单机构回顾性研究。
Virchows Arch. 2017 May;470(5):561-565. doi: 10.1007/s00428-017-2099-x. Epub 2017 Mar 9.
8
Effect of Age (over 75 Years) on Postoperative Complications and Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.年龄(75岁以上)对肝细胞癌肝切除患者术后并发症及生存的影响
J Gastrointest Surg. 2017 Apr;21(4):657-665. doi: 10.1007/s11605-016-3354-1. Epub 2017 Jan 12.
9
The potential effect of age on the natural behavior of bladder cancer: Does urothelial cell carcinoma progress differently in various age groups?年龄对膀胱癌自然行为的潜在影响:尿路上皮细胞癌在不同年龄组中的进展是否不同?
Kaohsiung J Med Sci. 2016 May;32(5):261-6. doi: 10.1016/j.kjms.2016.03.002. Epub 2016 Apr 10.
10
Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour.年轻成年人的尿路上皮膀胱癌:诊断、治疗及临床行为
Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E727-30. doi: 10.5489/cuaj.3049. Epub 2015 Oct 13.